Skip to main navigation Skip to search Skip to main content

What is the greatest regulatory challenge in the translation of biomaterials to the clinic?

  • Glenn D. Prestwich
  • , Sangeeta N Bhatia
  • , Christopher K. Breuer
  • , Shannon L M Dahl
  • , Chris Mason
  • , Richard McFarland
  • , David J. McQuillan
  • , Jonathan Sackner-Bernstein
  • , Jefrey Schox
  • , William E. Tente
  • , Alan Trounson

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Abstract

Leaders in the f eld comment on what they perceive to be the greatest barriers to biomaterial translation.

Original languageEnglish
Article number160cm14
JournalScience Translational Medicine
Volume4
Issue number160
DOIs
Publication statusPublished - 14 Nov 2012
Externally publishedYes

Cite this